UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of avian flu.

...GlaxoSmithKline ...company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. Net income fell to 1.31 billion pounds ($2.61 billion), or 24.2 pence a ...

410

...Glaxo ...Rises to Four Year High (Update1) Bloomberg GM Loses $15 5 Billion in Quarter New York Times Yahoo faces down shareholders at annual meeting MarketWatch Regulators Take Over Failing Bank ...

...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...

...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...